Frontotemporal Lobar Degeneration
Heterogeneous group of neurodegenerative disorders characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Multiple subtypes or forms are recognized based on presence or absence of TAU PROTEIN inclusions. FTLD includes three clinical syndromes: FRONTOTEMPORAL DEMENTIA, semantic dementia, and PRIMARY PROGRESSIVE NONFLUENT APHASIA.
Subtype terms (2)
More specific conditions that are subtypes of Frontotemporal Lobar Degeneration in the MeSH hierarchy.
- Frontotemporal Dementia
30 drugs (13 approved, 17 experimental)
- Primary Progressive Nonfluent Aphasia
5 drugs (1 approved, 4 experimental)
Drugs by status
Phase 4 trials (1)
Phase 3 trials (1)
Phase 2 trials (3)
Phase 1 trials (2)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 2 Indications (3)